During the past decade, Oviva UK ltd conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Oviva UK ltd" #1 collaborator was "Guy's and St Thomas' NHS Foundation Trust" with 1 trials as a collaborator and "University of Westminster" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Oviva UK ltd" are "Type 2 Diabetes" (1 trials) and "Type2diabetes" (1 trials). Many other conditions were trialed in "Oviva UK ltd" in a lesser frequency.

Most popular intervention types in "Oviva UK ltd" are "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Intermittent fasting 5:2" (1 trials), "Low-carbohydrate diet" (1 trials), "Total Diet Replacement (800kcal/day)" (1 trials) and "Total diet replacement" (1 trials). Other intervention names were less common.

The vast majority of trials in "Oviva UK ltd" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Oviva UK ltd". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Oviva UK ltd, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Oviva UK ltd, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".